David Kull
Direttore/Membro del Consiglio presso Rockwell Transportation, Inc.
Provenienza dei contatti di primo grado di David Kull
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Rockwell Transportation, Inc.
 Rockwell Transportation, Inc. Air Freight/CouriersTransportation Rockwell Transportation, Inc. engages in arrangement of freight and cargo transportation services. The company is headquartered in Wixom, MI.
2
| Subsidiary | Air Freight/Couriers | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a David Kull tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| ROCKWELL MEDICAL, INC. | Medical Specialties | Chief Executive Officer Director of Finance/CFO | |
Cantor Fitzgerald & Co.
 Cantor Fitzgerald & Co. Investment Banks/BrokersFinance Cantor Fitzgerald & Co. is the investment bank and brokerage subsidiary of CFS CF & Co. I Holdings LP, which is owned by Cantor Fitzgerald LP in the US. The firm was founded by Bernie Gerald Cantor and John Fitzgerald in 1945. Headquartered in New York City, Cantor Fitzgerald offers clients a global, multi-asset prime brokerage platform with a focus on the quality middle market. | Investment Banks/Brokers | Corporate Officer/Principal | |
| CORMEDIX INC. | Biotechnology | Chairman | |
Mt. Cook Pharma, Inc.
 Mt. Cook Pharma, Inc. Pharmaceuticals: MajorHealth Technology Mt. Cook Pharma, Inc. provides treatment for urological diseases. It offers services to overactive bladder, lower urinary symptoms, and interstitial cystitis diseases. The company was headquartered in Princeton, NJ. | Pharmaceuticals: Major | Director/Board Member | |
| AFFIMED N.V. | Biotechnology | Director of Finance/CFO | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| FIBROGEN, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Colgate University | College/University | Undergraduate Degree | |
| University of British Columbia | College/University | Doctorate Degree | |
| London School of Hygiene & Tropical Medicine | College/University | Graduate Degree | |
Promedior, Inc.
 Promedior, Inc. Medical SpecialtiesHealth Technology Promedior, Inc. is a clinical-stage immunotherapy company, which engages in the development of targeted therapeutics to treat fibrotic diseases. Its proprietary therapeutic platform is based upon Pentraxin-2, an endogenous human protein that plays an important role in regulating the response to fibrosis. The company was founded by Gomer H. Richard, Lawrence M. Kauvar, and Darrell Pilling in April 2006 and is headquartered in Lexington, MA. | Medical Specialties | Chief Executive Officer | |
Paramount BioSciences LLC
 Paramount BioSciences LLC Investment ManagersFinance Paramount BioSciences LLC (Paramount) is a venture capital firm founded in 1991. The firm is headquartered in New york. | Investment Managers | Corporate Officer/Principal | |
ProSanos Corp.
 ProSanos Corp. Medical/Nursing ServicesHealth Services ProSanos Corp. develops and provides healthcare solutions for the pharmaceutical and biotechnology industries. The company was founded by Jonathan A. Morris and Michael N. Liebman in 2000 and is headquartered in Harrisburg, PA. | Medical/Nursing Services | Director/Board Member | |
Torreya Partners LLC
 Torreya Partners LLC Investment ManagersFinance Torreya Partners LLC engages in provision of financial advisory services. The company was founded by Tim Opler and Mark Simon in 2007 and is headquartered in New York, NY. | Investment Managers | Director/Board Member | |
| ASSEMBLY BIOSCIENCES, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Bond Biosciences, Inc.
 Bond Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Bond Biosciences, Inc. engages in healthcare business. It focuses on small developing molecule based therapeutics for preventing iron absorption. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Executive Officer | |
| Alameda Consulting LLC | Corporate Officer/Principal | ||
Janssen Oncology, Inc.
 Janssen Oncology, Inc. Pharmaceuticals: MajorHealth Technology Janssen Oncology, Inc. engages in the development of pharmaceutical products for the treatment of cancer. It conducts pharmaceutical product trials. The company is headquartered in Los Angeles, CA. | Pharmaceuticals: Major | Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 21 |
| Germania | 2 |
| Canada | 2 |
| Regno Unito | 2 |
Settori
| Health Technology | 15 |
| Finance | 5 |
| Consumer Services | 4 |
| Health Services | 2 |
Posizioni
| Director/Board Member | 9 |
| Chief Tech/Sci/R&D Officer | 5 |
| Corporate Officer/Principal | 5 |
| Chief Executive Officer | 5 |
| President | 4 |
Contatti più connessi
| Insiders | |
|---|---|
| Russell Ellison | 20 |
| Angus Smith | 6 |
- Borsa valori
- Insiders
- David Kull
- Connessioni Società